Determinants of IBD-related disability: a cross-sectional survey from the GETAID.

Colitis, Ulcerative Cross-Sectional Studies Disability Evaluation France / epidemiology Humans Inflammatory Bowel Diseases / epidemiology Male

Journal

Alimentary pharmacology & therapeutics

ISSN: 1365-2036

Titre abrégé: Aliment Pharmacol Ther

Pays: England

ID NLM: 8707234

Informations de publication

Date de publication:
05 2021

Historique:

revised: 26 01 2021

received: 31 12 2020

accepted: 15 03 2021

pubmed: 6 4 2021

medline: 25 5 2021

entrez: 5 4 2021

Statut: ppublish

Résumé

The burden of inflammatory bowel disease (IBD) is rising worldwide. The goal of IBD treatment is to achieve clinical and endoscopic remission but also prevent disability. To identify the predictive factors of disability in a large population of patients with IBD. We conducted a cross-sectional survey in 42 tertiary centres in France and Belgium. A self-administered questionnaire was designed to explore patients and their IBD characteristics. IBD-disk is a validated tool to measure disability in patients with IBD. The IBD-disk score was then calculated for each patient. Based on a previous study, an overall IBD-disk score ≥40 was associated with moderate-to-severe disability. Among the 2011 patients, 1700 were analysed, including 746 (44%) in self-reported clinical remission and 752 (44.2%) declaring clinical activity. The patient global assessment of global remission was missing in 200 (11.8%) of 1700 patients. Moderate-to-severe disability was significantly increased in patients with BMI >25 kg/m Determinants of IBD-related disability include IBD-related factors but also psychological and social factors. This highlights the importance of a multidisciplinary team in the management of patients with IBD.

Sections du résumé

BACKGROUND

The burden of inflammatory bowel disease (IBD) is rising worldwide. The goal of IBD treatment is to achieve clinical and endoscopic remission but also prevent disability.

AIMS

To identify the predictive factors of disability in a large population of patients with IBD.

PATIENTS AND METHODS

We conducted a cross-sectional survey in 42 tertiary centres in France and Belgium. A self-administered questionnaire was designed to explore patients and their IBD characteristics. IBD-disk is a validated tool to measure disability in patients with IBD. The IBD-disk score was then calculated for each patient. Based on a previous study, an overall IBD-disk score ≥40 was associated with moderate-to-severe disability.

RESULTS

Among the 2011 patients, 1700 were analysed, including 746 (44%) in self-reported clinical remission and 752 (44.2%) declaring clinical activity. The patient global assessment of global remission was missing in 200 (11.8%) of 1700 patients. Moderate-to-severe disability was significantly increased in patients with BMI >25 kg/m

CONCLUSION

Determinants of IBD-related disability include IBD-related factors but also psychological and social factors. This highlights the importance of a multidisciplinary team in the management of patients with IBD.

Identifiants

DOI: 10.1111/apt.16353 PMID: 33817819

pubmed: 33817819

doi: 10.1111/apt.16353

doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

Pagination

1098-1107

Commentaires et corrections

Type : CommentIn

Informations de copyright

Références

Ramos A, Calvet X, Sicilia B, Vergara M, Villoria A, Gomollo F. IBD-related work disability in the community: prevalence, severity and predictive factors. A cross-sectional study. United Eur Gastroenterol J. 2015;3:335-342.

Paulides E, Frampton C, Gearry B. Overcoming workplace disability in IBD patients: an observational study. Inflamm Intest Dis. 2020;5:84-92.

Morreale GC, Calvaruso V, Sanfratello A, Cappello M. P658 The Inflammatory Bowel Disease Disability Index (IBD-DI) in ulcerative colitis is related to disease activity, need of immunosuppressive therapy and quality of life. J Crohn’s Colitis. 2017;11:S416.

World Health Organization Geneva. Towards a common language for functioning, disability and health: ICF. Int Classification. 2002;1149:1-22.

Gower-Rousseau C, Sarter H, Savoye G, et al. Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort Preliminary steps. Gut. 2017;66:588-596.

Ghosh S, Louis E, Beaugerie L, et al. Development of the IBD disk: a visual self-administered tool for assessing disability in inflammatory bowel diseases. Inflamm Bowel Dis. 2017;23:333-340.

Le Berre C, Flamant M, Bouguen G, et al. VALIDation of the IBD-Disk Instrument for Assessing Disability in Inflammatory Bowel Diseases in a French Cohort: the VALIDate study. J Crohns Colitis. 2021;14:1512-1523.

Tadbiri S, Nachury M, Bouhnik Y, et al. P248 validation of IBD-disk for the assessment of daily-life burden of patients with inflammatory bowel disease. J Crohns Colitis. 2020;14(Suppl._1):S272.

Isaacson PG. Update on MALT lymphomas. Best Pract Res Clin Haematol. 2005;18:57-68.

RC Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.

Siebert U, Wurm J, Gothe RM, et al. Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study. Inflamm Bowel Dis. 2013;19:847-855.

Allen PB, Gower-Rousseau C, Danese S, Peyrin-Biroulet L. Preventing disability in inflammatory bowel disease. Ther Adv Gastroenterol. 2017;10:865-876.

Turner J, Kelly B. Culture and medicine: emotional dimensions of chronic disease. West J Med. 2000;172:124-128.

Parker JC, Smarr KL, Buckelew SP, et al. Effects of stress management on clinical outcomes in rheumatoid arthritis. Arthritis Rheum. 1995;38:1807-1818.

Smyth JM, Stone AA, Hurewitz A, Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a randomized trial. JAMA. 1999;281:1304-1309.

Stabroth-Akil D, Leifeld L, Pfützer R, Morgenstern J, Kruis W. The effect of body weight on the severity and clinical course of ulcerative colitis. Int J Colorectal Dis. 2015;30:237-242.

Flores A, Burstein E, Cipher DJ, Feagins LA. Obesity in inflammatory bowel disease: a marker of less severe disease. Dig Dis Sci. 2015;60:2436-2445.

Nic ST, Raftery TC, McMahon O, Walsh C, O’Morain C, O’Sullivan M. High prevalence of overweight and obesity in adults with Crohn’s disease: associations with disease and lifestyle factors. J Crohns Colitis. 2013;7:e241-e248.

Mendall MA, Gunasekera AV, John BJ, Kumar D. Is obesity a risk factor for Crohn’s disease? Dig Dis Sci. 2011;56:837-844.

Pringle PL, Stewart KO, Peloquin JM, et al. Body mass index, genetic susceptibility, and risk of complications among individuals with Crohn’s disease. Inflamm Bowel Dis. 2015;21:2304-2310.

Pavelock N, Masood U, Minchenberg S, Heisig D. Effects of obesity on the course of inflammatory bowel disease. Proc (Bayl Univ Med Cent). 2019;32:14-17.

Jain A, Nguyen NH, Proudfoot JA, et al. Impact of obesity on disease activity and patient-reported outcomes measurement information system (PROMIS) in inflammatory bowel diseases. Am J Gastroenterol. 2019;114:630-639.

Singh S, Picardo S, Seow CH. Management of inflammatory bowel diseases in special populations: obese, old, or obstetric. Clin Gastroenterol Hepatol. 2020;18:1367-1380.